Rifampin-monoresistant tuberculosis in New York City, 1993-1994

Clinical Infectious Diseases

Volumn 25, Issue 6, 1997, Pages 1465-1467

  Munsiff, Sonal S ^a   Joseph, Shaunda ^b   Ebrahimzadeh, Adeleh ^b   Frieden, Thomas R ^b  

^a NEW YORK CITY DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ILLICIT DRUG; RIFAMPICIN;

ACID FAST BACTERIUM; ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CONTROLLED STUDY; DRUG RESISTANCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SPUTUM SMEAR; TUBERCULOSIS;

EID: 0031467418     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/516146     Document Type: Article

References (7)

1. Mitchison DA. Understanding the chemotherapy of tuberculosis: current problems. J Antimicrob Chemother 1992;29:477-93.
2. Mitchison DA, Nunn AJ. Influence of initial drug resistance on the response to short-course chemotherapy of pulmonary tuberculosis. Am Rev Respir Dis 1986;133:423-30.
3. Hawkins JE, Wallace RJ Jr, Brown BA. Antibacterial susceptibility tests: mycobacteria. In: Balows A, Hausler WJ Jr, Herrmann K, Isenberg HD, Shadomy HJ, eds. Manual of clinical microbiology. 5th ed. Washington, DC: American Society for Microbiology, 1991:1138-52.
4. Peloquin CA, Nitta A, Burman W, et al. Low antituberculosis drug concentrations in patients with AIDS. Ann Pharmacother 1996;30:919-25.
5. Patel KB, Belmonte R, Crowe HM. Drug malabsorption and resistant tuberculosis in HIV-Infected patients [letter]. N Engl J Med 1995;332:336-7.
6. Frieden TR, Sterling T, Pablos-Mendez A, Kilburn JO, Cauthen GA, Dooley SW. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 1993;328:521-6.
7. Frieden TR, Fujiwara PI, Washko RM, Hamburg MA. Tuberculosis in New York City - turning the tide. N Engl J Med 1995;333:229-33.